Skip to Content
Merck
  • Hepatitis B virus alters the antioxidant system in transgenic mice and sensitizes hepatocytes to Fas signaling.

Hepatitis B virus alters the antioxidant system in transgenic mice and sensitizes hepatocytes to Fas signaling.

PloS one (2012-05-19)
Qian Wang, Bing Na, Jing-hsiung James Ou, Lynn Pulliam, T S Benedict Yen
ABSTRACT

Hepatitis B virus (HBV) is a major etiological factor of hepatocellular carcinoma (HCC). However, the precise pathogenetic mechanisms linking HBV infection and HCC remain uncertain. It has been reported that decreased antioxidant enzyme activities are associated with severe liver injury and hepatocarcinogenesis in mouse models. It is unclear if HBV can interfere with the activities of antioxidant enzymes. We established a HBV transgenic mouse line, which spontaneously developed HCC at 2 years of age. We studied the activities of the antioxidant enzymes in the liver of the HBV transgenic mice. Our results showed that the antioxidant enzymes glutathione peroxidase and superoxide dismutase 2 were down-regulated in HBV transgenic mice and correlated with JNK activation. HBV enhanced the Fas-mediated activation of caspase 6, caspase 8 and JNK without enhancing the activation of caspase 3 and hepatocellular apoptosis. As a proper redox balance is important for maintaining cellular homeostasis, these effects of HBV on the host antioxidant system and Fas-signaling may play an important role in HBV-induced hepatocarcinogenesis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Mn-SOD Antibody, Upstate®, from rabbit
Sigma-Aldrich
Superoxide Dismutase from human erythrocytes, essentially salt-free, lyophilized powder, ≥2,500 units/mg protein
Sigma-Aldrich
SOD Assay Kit, sufficient for 500 tests